Investing.com - Omeros reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
Omeros announced earnings per share of $-0.28 on revenue of $0.00. Analysts polled by Investing.com anticipated EPS of $-0.56 on revenue of $0.00.
Omeros shares are down 29.95% from the beginning of the year , still down 67.21% from its 52 week high of $8.60 set on Monday, November 15, 2021.
Omeros follows other major Healthcare sector earnings this month
Omeros's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar